Skip to main content
BRAIN Biotech AG logo

BRAIN Biotech AG — Investor Relations & Filings

Ticker · BNN ISIN · DE0005203947 LEI · 391200JKPVHLD6JLZ107 F Professional, scientific and technical activities
Filings indexed 368 across all filing types
Latest filing 2017-05-26 Report Publication Anno…
Country DE Germany
Listing F BNN

About BRAIN Biotech AG

https://www.brain-biotech.com/

BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2017
Report Publication Announcement Classification · 100% confidence The document is very short (1795 characters) and explicitly states that it is a 'Preliminary announcement of the publication of financial reports'. It specifies the report type ('Financial report of the group (half-year/Q2)') and provides the future disclosure date (May 31, 2017) and links where the report will be available. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report will be published or is attached should be classified as a Report Publication Announcement (RPA). It is not the comprehensive Interim Report (IR) itself, but the notice about its release.
2017-05-26 English
Hinweis auf Halbjahresfinanzbericht vom 01.10.2016 bis zum 31.03.2017
Report Publication Announcement Classification · 100% confidence The document is a short notification (849 characters) informing stakeholders that the semi-annual financial report for the period 01.10.2016 to 31.03.2017 has been published and provides a link to access it on the company's website. Per the 'Menu vs Meal' rule, since this is an announcement of a report rather than the report itself, it is classified as a Report Publication Announcement (RPA).
2017-05-26 German
Datum:26.05.2017
Report Publication Announcement Classification · 100% confidence The document is a short notification (828 characters) informing stakeholders that the semi-annual financial report for the period 01.10.2016 to 31.03.2017 is available on the company's website. It does not contain the financial report itself, but rather acts as a formal announcement of its publication. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2017-05-26 German
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG expands patent protection for Aurase(R) enzyme for the treatment of chronic wounds
Regulatory Filings Classification · 100% confidence The document is a news release dated March 21, 2017, disseminated via DGAP, which is a service for regulatory announcements and press releases. The content details a specific corporate event: BRAIN AG expanding patent protection for its Aurase(R) enzyme and engaging in partnership discussions. This is not a comprehensive annual report (10-K), an interim report (IR), an earnings release (ER), or a formal shareholder communication like a proxy statement (PSI) or AGM material (AGM-R). It is a specific, time-sensitive announcement about business development (patent expansion) that is typically distributed as a press release or regulatory filing. Since it is a specific corporate update that doesn't fit the highly specialized categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Capital Change (CAP), and it is not merely announcing the publication of a larger report (RPA), the most appropriate general category for a non-standard, specific corporate news item distributed via a regulatory news service (DGAP) is Regulatory Filings (RNS).
2017-03-21 English
Declaration of Voting Results & Voting Rights Announcements 2017
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership ('Notification of Major Holdings'). It specifies the date the threshold was crossed (09 March 2017) and the resulting percentage of voting rights (3.66%). This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which maps to the Major Shareholding Notification code (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a specific disclosure of a major holding change, which is better classified as MRQ than DVA (which is for voting results) or RNS (which is a fallback).
2017-03-14 English
B.R.A.I.N. Biotechnology Research And Information Network AG: BRAIN AG successfully concludes first Annual General Meeting as a stock listed company
AGM Information Classification · 100% confidence The document explicitly states in the title and body that it concerns the 'Annual General Meeting' (AGM). Key phrases include 'BRAIN AG successfully concludes first Annual General Meeting as a stock listed company', 'At the Annual General Meeting 70,77% of the total share capital... was represented', and the DGAP keyword is 'AGM/EGM'. This directly maps to the AGM Information category.
2017-03-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.